Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites

Virchows Archiv

Volumn 454, Issue 5, 2009, Pages 513-517

  Sekine, Shigeki ^a   Nakanishi, Yukihiro ^a   Ogawa, Reiko ^a   Kouda, Satoko ^a   Kanai, Yae ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

BRAF; Esophageal melanoma; KIT; NRAS

Indexed keywords

B RAF KINASE; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; ESOPHAGEAL MELANOMA; ESOPHAGUS CANCER; EXON; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC TRAIT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; ONCOGENE N RAS; PREVALENCE; PRIORITY JOURNAL;

AGED; CYTOSINE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GUANINE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUCOUS MEMBRANE; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-KIT; RAS PROTEINS;

EID: 67349195438     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0762-6     Document Type: Article

References (22)

1. LJ van't Veer BM Burgering R Versteeg 1989 N-ras mutations in human cutaneous melanoma from sun-exposed body sites Mol Cell Biol 9 3114 3116 (Pubitemid 19163079)
2. S Jiveskog B Ragnarsson-Olding A Platz 1998 N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin J Invest Dermatol 111 757 761 (Pubitemid 28509314)
3. H Davies GR Bignell C Cox 2002 Mutations of the BRAF gene in human cancer Nature 417 949 954 (Pubitemid 34716871)
4. JA Curtin J Fridlyand T Kageshita 2005 Distinct sets of genetic alterations in melanoma N Engl J Med 353 2135 2147 (Pubitemid 41653105)
5. JA Curtin K Busam D Pinkel 2006 Somatic activation of KIT in distinct subtypes of melanoma J Clin Oncol 24 4340 4346 (Pubitemid 46630793)
6. RS Rivera H Nagatsuka M Gunduz 2008 C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma Virchows Arch 452 27 32
7. CR Antonescu KJ Busam TD Francone 2007 L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition Int J Cancer 121 257 264 (Pubitemid 46917693)
8. H Kato H Watanabe Y Tachimori 1991 Primary malignant melanoma of the esophagus: report of four cases Jpn J Clin Oncol 21 306 313
9. B Li W Lei K Shao 2007 Characteristics and prognosis of primary malignant melanoma of the esophagus Melanoma Res 17 239 242 (Pubitemid 47067082)
10. CM Lohmann WJ Hwu K Iversen 2003 Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens Melanoma Res 13 595 601 (Pubitemid 38296897)
11. AD Turnbull P Rosen JT Goodner 1973 Primary malignant tumors of the esophagus other than typical epidermoid carcinoma Ann Thorac Surg 15 463 473
12. J Scotto JF Fraumeni Jr JA Lee 1976 Melanomas of the eye and other noncutaneous sites: epidemiologic aspects J Natl Cancer Inst 56 489 491
13. R Tateishi H Taniguchi A Wada 1974 Argyrophil cells and melanocytes in esophageal mucosa Arch Pathol 98 87 89
14. T Hocker H Tsao 2007 Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants Hum Mutat 28 578 588 (Pubitemid 46744288)
15. Y Cohen E Rosenbaum S Begum 2004 Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites Clin Cancer Res 10 3444 3447 (Pubitemid 38685451)
16. RH Edwards MR Ward H Wu 2004 Absence of BRAF mutations in UV-protected mucosal melanomas J Med Genet 41 270 272 (Pubitemid 38496770)
17. CW Wong YS Fan TL Chan 2005 BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs J Clin Pathol 58 640 644 (Pubitemid 40814027)
18. J Lasota M Jasinski M Sarlomo-Rikala 1999 Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas Am J Pathol 154 53 60 (Pubitemid 29031611)
19. FS Hodi P Friedlander CL Corless 2008 Major response to imatinib mesylate in KIT-mutated melanoma J Clin Oncol 26 2046 2051
20. J Lutzky J Bauer BC Bastian 2008 Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation Pigment Cell Melanoma Res 21 492 493
21. KT Montone P van Belle R Elenitsas 1997 Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression Mod Pathol 10 939 944 (Pubitemid 27431970)
22. F Janku J Novotny I Julis 2005 KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients Melanoma Res 15 251 256 (Pubitemid 41127460)